Clinical trial
A Phase I/II Study of JR-141 in Patients With Mucopolysaccharidosis Type II
NCT03128593 is registered in ClinicalTrials.gov with JCR Pharmaceuticals Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/II Study of JR-141 in Patients With Mucopolysaccharidosis Type II
- Lead sponsor
- JCR Pharmaceuticals Co., Ltd.
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- March 30, 2017
- Completion date
- October 4, 2017
- Enrollment
- 14 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.